Washington Trust Bank’s Innoviva INVA Stock Holding History

Washington Trust Bank’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-43	Closed	–	–	817
2016 Q4	$0	Hold	43	–	–	﹤0.01%	1062
2016 Q3	$0	Buy	+43	New	+$502	﹤0.01%	1139

Other funds holding INVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Washington Trust Bank's INVA Position: Q1 2017 in Review

Washington Trust Bank sold out of Innoviva (INVA) in Q1 2017, closing a stake of 43 shares.

Washington Trust Bank first reported a position in INVA in Q3 2016 and held it in 2 quarters. The position peaked at $0 in Q4 2016. 164 funds tracked by Wall St. Rank hold INVA as of Q1 2017.

Washington Trust Bank reported no remaining Innoviva position as of Q1 2017 after selling out during the quarter.
Washington Trust Bank sold 43 Innoviva shares in Q1 2017.
Washington Trust Bank first reported a position in Innoviva in Q3 2016 and held it in 2 quarters.
Washington Trust Bank's Innoviva position peaked at $0 in Q4 2016.
164 funds tracked by Wall St. Rank held Innoviva as of Q1 2017.

Based on Washington Trust Bank's 13F filing for Q1 2017, filed 18 Apr 2017.